Back to top
more

Teleflex (TFX)

(Delayed Data from NYSE)

$201.92 USD

201.92
640,750

-1.58 (-0.78%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $201.74 -0.18 (-0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (89 out of 251)

Industry: Medical - Instruments

Zacks News

Teleflex (TFX) Procedure Volume Recovers as Pandemic Subsides

The UroLift System remains a major contributor to Teleflex (TFX) revenues.

TeleFlex (TFX) Urolift Grows, Organic Sales Hit by Pandemic

On the strength of a successful 2020 campaign, Teleflex (TFX) doubles the awareness for UroLift in the targeted population of men with BPH.

Teleflex (TFX) Beats on Q1 Earnings and Revenues, Raises View

The acquisition of Z-Medica and an increase in sales of new products contribute to Teleflex's (TFX) revenue growth in Americas in Q1

Teleflex (TFX) Q1 Earnings and Revenues Top Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 17.62% and 2.04%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Teleflex (TFX) to Report a Decline in Earnings: What to Look Out for

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why Is Teleflex (TFX) Up 2.6% Since Last Earnings Report?

Teleflex (TFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Teleflex (TFX) Beats on Q4 Earnings and Revenues, Margins Fall

Teleflex (TFX) witnesses significant sequential improvement in segmental performance during the fourth quarter on gradual recovery of the economy.

Teleflex (TFX) Beats Q4 Earnings and Revenue Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 7.26% and 3.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Teleflex (TFX) Q4 Earnings Expected to Decline

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TeleFlex (TFX) Organic Sales Hit by COVID-19, Urolift Grows

TeleFlex (TFX) Interventional business revenues are down due to the cancellation of certain non-emergent procedures.

Teleflex (TFX) Completes Buyout of Hemostatic Goods Producer

Teleflex (TFX) to leverage its strength in enhancing clinical efficacy and patient safety via the recent buyout.

Teleflex (TFX) Hurt by COVID-19-Led Disruption, UroLift Grows

Teleflex (TFX) expects further adverse financial impact of the coronavirus pandemic.

Teleflex (TFX) Q3 Earnings & Revenues Beat, Decline Y/Y

Teleflex (TFX) witnesses significant sequential improvement in segmental performance on gradual recovery of the economy.

Teleflex (TFX) Q3 Earnings and Revenues Surpass Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 22.03% and 1.27%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

Medical Products' Oct 29 Earnings Roster: SYK, BAX & More

Medical Product companies have shown strength in the third quarter on the back of huge adoption of COVID-19 related healthcare-support products and services despite the impact of the ongoing pandemic.

Earnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Teleflex's (TFX) Arrow EZ-IO Gets FDA's Expanded Indications

Teleflex's (TFX) recent expanded indications for its IO device provide more time to physicians to establish safe vascular access.

How Has TFX Performed 30 Days Post Earnings

Teleflex (TFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TeleFlex Banks on Urolift Sales Amid Coronavirus-Led Debacle

The acquired business of Teleflex (TFX), NeoTract has been performing impressively lately.

Teleflex (TFX) Beats Q2 Earnings Estimates, Margins Contract

Teleflex (TFX) sales grow within the Americas attributable to Vascular Access and respiratory products, driven by COVID-19-led elevated demand.

Teleflex (TFX) Q2 Earnings and Revenues Surpass Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 55.65% and 6.46%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health (OPK) to Report Q2 Earnings: What's in Store?

OPKO Health's (OPK) second-quarter results are likely to reflect solid performance from Products segment and RAYALDEE.

Trina Mukherjee headshot

Medical Products Stock Earnings on Jul 30: BAX, SYK & More

Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.

Teleflex (TFX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Teleflex (TFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Hold on to Teleflex (TFX) Stock for Now

Investors continue to be optimistic about Teleflex (TFX) on robust segmental and geographical growth.